Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism
Year: 2000
Type: article
Study design: Clinical Trial
Source: Journal of Child Neurology
Language: English
Subfield: Cognitive Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
Funder: Pfizer Pharmaceuticals
OpenAlex ID: W2020523926
